Aarti Drugs Q2 Results FY27: PAT Jumps 83.28% To Rs 82.77 Cr, Revenue Rs 826.24 Cr, PAT Rs 82.77 Cr

Aarti Drugs Ltd (AARTIDRUGS) Q2 Results FY27 announced on 3 November 2026, covering the company's financial performance for the July to September quarter. The results date is 3 November, and the numbers are consolidated results: revenue of Rs 826.24 Cr and net profit of Rs 82.77 Cr. Aarti Drugs Q2 Results FY27 also report Operating Profit of Rs 135.36 Cr, up from Rs 84.28 Cr.

Readers of this Aarti Drugs Q2 Results results analysis will find the financial highlights, the disclosed business drivers, the FY27 outlook and the risks in one place, built from figures Univest compiled for the quarter. The Financial Highlights table sits directly below, so the results analysis can start from the reported numbers.

Click Here – Get Free Investment Predictions

Aarti Drugs Q2 Results FY27: Financial Highlights

Metric	Q2 FY27 (Sep 26)	Q2 FY26 (Sep 25)	YoY Change
Revenue	Rs 826.24 Cr	Rs 652.79 Cr	+26.57% YoY
Operating Profit	Rs 135.36 Cr	Rs 84.28 Cr	+60.61% YoY
Net Profit (PAT)	Rs 82.77 Cr	Rs 45.16 Cr	+83.28% YoY

Source: company filing for Aarti Drugs Q2 Results FY27, 3 November 2026. Figures in Rs Crore, Consolidated basis.

Key Takeaways from Aarti Drugs Q2 Results: What Stands Out

• Revenue of Rs 826.24 Cr is 26.57% higher than the Rs 652.79 Cr booked in the corresponding quarter of last year.
• Operating Profit of Rs 135.36 Cr compares with Rs 84.28 Cr a year ago, an increase of 60.61% on the same base.
• Net profit of Rs 82.77 Cr is up 83.28% from Rs 45.16 Cr, and Aarti Drugs Q2 Results FY27 show YoY growth that is widest on this bottom line.
• Net profit margin of 10.0% replaces 6.9% in the comparison quarter, so each rupee of sales left more behind.
• The performance analysis next places the three profit-and-sales lines against each other.

Aarti Drugs Q2 Results FY27: Performance Analysis

Aarti Drugs posted consolidated revenue of Rs 826.24 Cr for July to September 2026, which is 26.57% above Rs 652.79 Cr a year earlier. Operating Profit reached Rs 135.36 Cr and net profit reached Rs 82.77 Cr, so the quarterly results show a rise on all three lines.

A results analysis of Aarti Drugs Q2 Results FY27 turns on the order of the growth rates: revenue grew 26.57%, Operating Profit grew 60.61% and net profit grew 83.28%. Each rate is larger than the one before it, which is why the net profit margin moved from 6.9% to 10.0% over the year. Put differently, the Rs 135.36 Cr of Operating Profit and the Rs 82.77 Cr of net profit both rose by more than the revenue line did.

Investors following Aarti Drugs Q2 Results will watch whether profit keeps pace with sales when the next filing arrives, because the YoY growth here is measured against a lower base of Rs 45.16 Cr. The numbers confirm what changed rather than the cause, so the results analysis moves on to the business factors that were disclosed.

Check the Univest Screener for live results data

Key Business Factors This Quarter

Revenue Growth – The results analysis begins with sales, which grew 26.6% year on year to Rs 826.24 Cr in the latest quarter and set the scale for everything below it in Aarti Drugs Q2 Results FY27.

Net Profit Rise – Net profit rose 83.3% year on year to Rs 82.77 Cr, so the quarterly results show earnings advancing at a pace well ahead of the sales growth that preceded it in the table.

Improved Net Profit Margin – Net profit margin improved to 10.0% from 6.9% in the comparison quarter, a gain of 3.1 percentage points that explains how profit outgrew revenue over the same twelve months.

FY27 Outlook After Aarti Drugs Q2 Results

No management guidance is attached to these figures, so the FY27 view depends on the quarters that remain. The results analysis therefore reads net profit of Rs 82.77 Cr as a single data point, to be checked against later filings and the sector conditions that companies disclose.

The next filing will show whether the pattern in Aarti Drugs Q2 Results FY27 holds, narrows or reverses, and the Operating Profit of Rs 135.36 Cr gives a second reference alongside net profit. Until then, the quarter stands as reported on a consolidated basis, with sales of Rs 826.24 Cr as the base for any comparison. Its volatility against recent quarters leads straight into the risks.

Key Risks to Watch After Aarti Drugs Q2 Results FY27

Volatile Quarterly Net Profit

Quarterly net profit has been volatile, ranging from Rs 40.54 Cr to Rs 82.77 Cr over the last 5 quarters. After Aarti Drugs Q2 Results FY27, that spread means one quarter, even one with 83.28% growth in net profit, does not settle the trend for the full year.

Lower Return on Capital Employed

Return on capital employed declined to 12.04% in FY26 from 13.11% in FY25. This annual ratio sits alongside the YoY growth in the latest quarter and shows that returns on capital were lower over the full year.

Download the Univest iOS App or Univest Android App to track quarterly results as they are declared.

Conclusion

Aarti Drugs Q2 Results FY27 record consolidated revenue of Rs 826.24 Cr, up 26.57% YoY, Operating Profit of Rs 135.36 Cr and net profit of Rs 82.77 Cr, up 83.28%. The quarterly results are consolidated results, and each figure is compared with the same quarter last year. Readers who track Aarti Drugs Q2 Results can use the Univest Screener, to compare this filing with other companies, and should consult a SEBI-registered advisor before acting.

Frequently Asked Questions on Aarti Drugs Q2 Results FY27

What are Aarti Drugs Q2 Results FY27?

Ans. Aarti Drugs Q2 Results FY27 cover July to September 2026, with consolidated revenue of Rs 826.24 Cr and net profit of Rs 82.77 Cr, while the Financial Highlights table lists each reported line.

What is the results date for Aarti Drugs Q2 Results FY27?

Ans. Aarti Drugs declared its Q2 FY27 results on 3 November 2026, so every comparison in this article is tied to that filing, as the introduction explains.

What revenue was reported in Aarti Drugs Q2 Results FY27?

Ans. Aarti Drugs reported revenue of Rs 826.24 Cr for the quarter, compared with Rs 652.79 Cr a year earlier, as the Performance Analysis section sets out in detail.

What net profit was reported in Aarti Drugs Q2 Results FY27?

Ans. Aarti Drugs reported net profit of Rs 82.77 Cr, compared with Rs 45.16 Cr a year earlier, which is why the Key Takeaways section calls it the widest gain.

How much YoY growth did revenue show in Aarti Drugs Q2 Results FY27?

Ans. Revenue showed YoY growth of 26.57%, rising from Rs 652.79 Cr to Rs 826.24 Cr, while net profit grew faster, as the Performance Analysis section explains alongside it.

Did net profit rise or fall in Aarti Drugs Q2 Results?

Ans. Net profit rose 83.28% to Rs 82.77 Cr from Rs 45.16 Cr, so profit grew faster than revenue, as the Key Takeaways section shows in its third point.

What was the Operating Profit in Aarti Drugs Q2 Results FY27?

Ans. Operating Profit was Rs 135.36 Cr, compared with Rs 84.28 Cr a year earlier, a rise of 60.61%, which the Performance Analysis section places between revenue and net profit growth.

Are Aarti Drugs Q2 Results consolidated results or standalone results?

Ans. The figures are consolidated results, covering the group rather than the parent alone, so every revenue and net profit number in the Financial Highlights table is on a Consolidated basis.

What business factors shaped Aarti Drugs Q2 Results FY27?

Ans. The disclosed factors are 26.6% YoY revenue growth, an 83.3% rise in net profit and a margin of 10.0% against 6.9%, which the Key Business Factors section covers in order.

What are the key risks after Aarti Drugs Q2 Results FY27?

Ans. The risks are quarterly net profit ranging from Rs 40.54 Cr to Rs 82.77 Cr and return on capital employed of 12.04% in FY26, both explained in the Key Risks section.

What is the outlook after Aarti Drugs Q2 Results?

Ans. No management guidance is attached to the quarter, so the FY27 outlook depends on later quarters and disclosed sector conditions, as the Outlook section explains in relation to the Rs 82.77 Cr net profit.

Where can I find the complete Aarti Drugs Q2 Results FY27 data?

Ans. The complete figures are in the Financial Highlights table of this article and in the Univest Screener, which lists Aarti Drugs alongside other companies that have declared quarterly results.